RxDoctor Payments Data

Stanley Cohen

Pediatrics · New York, NYNPI 1114085750

Payments from drug & device makers

$10,268in general payments, 2019–2025

Across 306 payments — averaging $33.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$3K
  • AstraZeneca$2K
  • Boehringer Ingelheim$976
  • Regeneron Healthcare Solutions, Inc.$805
  • Novo Nordisk$576
  • Genentech USA, Inc.$432
  • plus $2K from 13 others

What the payments were for

  • Food & beverage$10,11899%
  • Education$1501%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,268 in reported general payments places this provider in the 95th percentile of 4,055 pediatrics providers in New York.

See all pediatrics providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
OfevNintedanib Esylate141$1,931,716
Trelegy ElliptaFluticasone/Umeclidin/Vilanter841$617,258
Incruse ElliptaUmeclidinium Bromide323$117,858
TezspireTezepelumab-Ekko22$92,830
Fasenra PenBenralizumab14$77,933
Dupixent PenDupilumab19$67,634
Breo ElliptaFluticasone/Vilanterol156$67,240
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr96$51,143
TrulicityDulaglutide47$50,234
VascepaIcosapent Ethyl76$30,215
Arnuity ElliptaFluticasone Furoate137$28,836
OzempicSemaglutide18$16,315
Azelastine Hcl1,276$16,307
Qvar RedihalerBeclomethasone Dipropionate51$13,735
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$13,729

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimOfev$976$1,931,716141 claims
GSKTrelegy Ellipta, Incruse Ellipta, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta$3,327$882,3351,553 claims
AstraZenecaTezspire, Breztri Aerosphere, Farxiga$2,135$113,64249 claims
Novo NordiskOzempic$576$16,31518 claims
AbbVieLinzess$37$6,07412 claims
ANI Pharmaceuticals, Inc.Valsartan$51$4,388158 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,055 pediatrics providers in New York.

Other pediatrics in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →